History
We have the resolute commitments to improve patients access to high quality and affordable medicines, to facilitate healthcare security, and to care for the health of Thai people and beyonds. Siam Bioscience group has been established since 2009, consisted of 2 major companies–Siam Bioscience Co.,Ltd. and Apexcela Co.,Ltd.
• Siam Bioscience focuses on research, development and manufacturing of biopharmaceuticals, pharmaceuticals, medical devices, and related healthcare products. The company conducts comprehensive R&D and manufacturing starting from active pharmaceutical ingredients and biological active substances to final dosage forms and finished products.
• Apexcela focuses on sales, marketing, and distribution of Siam Bioscience products, including business development aiming to build partnerships both in Thailand and worldwide.
Our main objective is to manufacture biopharmaceuticals using state-of-the-art and efficient technology. Biopharmaceuticals can treat many diseases effectively with low side effects. Our companies have started producing and commercializing biopharmaceuticals since 2016, launching erythropoietin for anemia and filgrastim for neutropenia. Our plant achieved PIC/s GMP, and ISO17025:2016. Our products are available through all reimbursement schemes in Thailand
Our world-class quality standards and comprehensive R&D coupled with business development capabilities have led us to be awarded contract development and manufacturing agreements of medicines and medical devices for various organizations, both in Thailand and worldwide.
In 2017, Siam Bioscience Group expanded business further by establishing 2 subsidiaries.
• Abinis Co., Ltd. is the joint venture company with CIMAB (Cuba) for R&D, manufacturing, and commercialization of mammalian cell culture derived biopharmaceuticals for treatment of various diseases such as cancer, autoimmune diseases, and anemia with focus on exportation.
• Inno Biocosmed Co., Ltd. is a wholly-owned subsidiary of Siam Bioscience for commercialization of biocosmeceuticals which are developed and manufactured by Siam Bioscience Group.
History
We have the resolute commitments to improve patients access to high quality and affordable medicines, to facilitate healthcare security, and to care for the health of Thai people and beyonds. Siam Bioscience group has been established since 2009, consisted of 2 major companies–Siam Bioscience Co.,Ltd. and Apexcela Co.,Ltd.
• Siam Bioscience focuses on research, development and manufacturing of biopharmaceuticals, pharmaceuticals, medical devices, and related healthcare products. The company conducts comprehensive R&D and manufacturing starting from active pharmaceutical ingredients and biological active substances to final dosage forms and finished products.
• Apexcela focuses on sales, marketing, and distribution of Siam Bioscience products, including business development aiming to build partnerships both in Thailand and worldwide.
Our main objective is to manufacture biopharmaceuticals using state-of-the-art and efficient technology. Biopharmaceuticals can treat many diseases effectively with low side effects. Our companies have started producing and commercializing biopharmaceuticals since 2016, launching erythropoietin for anemia and filgrastim for neutropenia. Our plant achieved PIC/s GMP, and ISO17025:2016. Our products are available through all reimbursement schemes in Thailand
Our world-class quality standards and comprehensive R&D coupled with business development capabilities have led us to be awarded contract development and manufacturing agreements of medicines and medical devices for various organizations, both in Thailand and worldwide.
In 2017, Siam Bioscience Group expanded business further by establishing 2 subsidiaries.
• Abinis Co., Ltd. is the joint venture company with CIMAB (Cuba) for R&D, manufacturing, and commercialization of mammalian cell culture derived biopharmaceuticals for treatment of various diseases such as cancer, autoimmune diseases, and anemia with focus on exportation.
• Inno Biocosmed Co., Ltd. is a wholly-owned subsidiary of Siam Bioscience for commercialization of biocosmeceuticals which are developed and manufactured by Siam Bioscience Group.
Siam Bioscience Group, established in 2009, believed that accessibility to high quality and effective healthcare products is the basic rights for all. This is particularly important for the current trend of aging society where health problems such as cancer and autoimmune diseases have become more prevalent. We strive to research, develop, and manufacture world-class products for public health security and well-being of all people.
Corporate Value
Siam Bioscience Group has corporate core value for our employees called “PROMPT2”
Corporate Value
Siam Bioscience Group has corporate core value for our employees called ” GROWTH ” which stands for:
G = GROWTH MINDSET
R = RESULTS
O = OWNERS’ MENTALITY
W = WILLINGNESS
T = TRUSTWORTHINESS
H = HARMONY